Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
30,767,343
-
Total 13F shares
-
3,292,636
-
Share change
-
+490,520
-
Total reported value
-
$44,309,081
-
Put/Call ratio
-
74900%
-
Price per share
-
$13.46
-
Number of holders
-
47
-
Value change
-
+$5,759,071
-
Number of buys
-
26
-
Number of sells
-
14
Institutional Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q3 2016
As of 30 Sep 2016,
XBiotech Inc. - Common Shares, no par value (XBIT) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,292,636 shares.
The largest 10 holders included
BlackRock Fund Advisors, VANGUARD GROUP INC, STATE STREET CORP, BlackRock Institutional Trust Company, N.A., NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, CADIAN CAPITAL MANAGEMENT, LP, Bank of New York Mellon Corp, BlackRock Investment Management, LLC, and SCHWAB CHARLES INVESTMENT MANAGEMENT INC.
This page lists
47
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.